
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+1
Med-Fine Capital, with offices in Shanghai and Beijing, specializes in investments in healthcare and life sciences. Our management team boasts a global perspective, deep industry expertise, extensive resources, and professional investment experience. We manage several RMB funds and USD funds, focusing on early-stage value and on-track opportunities discovery in biotech, device, diagnostics, digital and services. To date, we have invested in approximately 70 companies, including Hanyu Medical, Mabworks, ImmVira Pharma, Zion Pharma, LYNK Pharmaceuticals, Eccogene, Pharma Legacy, MagAssist, Alebund, Allorion Therapeutics, SAFE Pharmaceutical, Arthrone Technology, AccuPulse, and SMJH-Bio. Guided by our vision to be the bridge between nations and shape...
Biotechnology,healthcare investment,healthcare,financial services,fund management,and investment management
Med-fine capital operates in the Investment management industry.
Med-fine capital's revenue is 11m - 100m
Med-fine capital has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.